The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

Thanks to predictive and preventive medicine. The global immunoassay market is projected to grow by $8.64b until 2028 at a compound annual growth rate of 4.42%, said Technavio. The sector’s ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...

The IMMULITE ® 2000 XPi Immunoassay System from Siemens Healthineers makes it simple to scale capabilities without disrupting regular day-to-day operations by providing multiple tests on a single ...

Ahomebrewbead-based immunoassay begins with the capture and labeling of an analyte using an enzyme conjugate (streptavidin ß-galactosidase, SBG). The analyte is captured with beads, and a ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) ...

Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...

With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.